Mayne Pharma Group Ltd.ASX: MYX

Court approves convening of scheme meeting

· Issued by Mayne Pharma Group Ltd.

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Mayne Pharma Group Ltd. has announced that the Supreme Court of New South Wales has approved the convening of a meeting for shareholders to vote on a proposed scheme of arrangement with Cosette Pharmaceuticals. The Independent Expert has concluded that the scheme is fair and in the best interests of Mayne Pharma shareholders, and the directors recommend voting in favor of it. The Scheme Meeting is scheduled to take place as a hybrid meeting, allowing shareholders to participate both in person and online. The Scheme Booklet, which contains detailed information about the scheme, will be distributed to shareholders following its registration with the Australian Securities and Investments Commission.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Mayne Pharma Group Ltd. on 6ix

Story so far

Earlier from Mayne Pharma

Later from Mayne Pharma

All Mayne Pharma news releases